发明名称 Aptameric IgE peptides in a protein scaffold as an allergy vaccine
摘要 A method is disclosed wherein an antigenic B-cell epitope is discovered by in vitro transcription and translation of pre-determined sequence on thermostable protein scaffolds detected by antibodies to a native protein. Immune reactivities of IgE B-cell epitopes from pre-determined IgE sequences from the constant region, engaged in binding to high affinity IgE Fc receptors, placed in a loop of green fluorescent protein (GFP) were shown immuno-reactive with anti-IgE. Moreover, the antigenic B-cell epitope can be further optimized by molecular evolution, selected by conformer antibody and receptor on solid phase via ribosome display. Alternatively, a random aptameric antigenic sequence inserted into a loop of the protein scaffold, mimicking a pre-determined sequence of a native protein, can be selected by solid phase conformer antibody and receptor via ribosome display. High affinity binding of B-cell epitopes selected from the random aptameric library with antibodies to native pre-determined B-cell epitope of a native protein can be optimized by molecular evolution with error-prone RT-PCR by ribosome display.
申请公布号 US8865179(B2) 申请公布日期 2014.10.21
申请号 US200812011303 申请日期 2008.01.26
申请人 Swey-Shen Alexchen 发明人 Chen Swey-Shen Alex
分类号 A61K39/00;G01N33/68;C07K16/42;C07K14/705 主分类号 A61K39/00
代理机构 代理人
主权项 1. An aptameric IgE peptide fused in a protein scaffold wherein the IgE peptide is chosen from the group consisting of SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 14, SEQ ID NO: 16, and SEQ ID NO: 18, and wherein the aptameric IgE peptidic protein scaffold is a fusion protein.
地址 San Diego CA US